Atherosclerosis Risk in Communities (ARIC) Carotid MRI Flow Cytometry Study of Monocyte and Platelet Markers: Intraindividual Variability and Reliability
Catellier et al.
Clin. Chem. 2008;54:1363-1371.
ABSTRACT
| FULL TEXT
Endothelial function and inflammation in coronary artery disease
Tousoulis et al.
Postgrad. Med. J. 2008;84:368-371.
ABSTRACT
| FULL TEXT
Novel biomarkers--the long march from bench to bedside
Weber and Hamm
Eur Heart J 2008;29:1079-1081.
FULL TEXT
Protective Role of CXC Receptor 4/CXC Ligand 12 Unveils the Importance of Neutrophils in Atherosclerosis
Zernecke et al.
Circ. Res. 2008;102:209-217.
ABSTRACT
| FULL TEXT
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease
Brevetti et al.
Eur Heart J 2008;29:224-230.
ABSTRACT
| FULL TEXT
Peripheral arterial disease enters the biomarker era. Does risk stratification tell us something that we don't already know?
Gornik
Eur Heart J 2008;29:150-152.
FULL TEXT
Biological Variation of Myeloperoxidase
Dednam et al.
Clin. Chem. 2008;54:223-225.
FULL TEXT
Accumulation of Myeloperoxidase-Positive Neutrophils in Atherosclerotic Lesions in LDLR / Mice
van Leeuwen et al.
Arterioscler. Thromb. Vasc. Bio. 2008;28:84-89.
ABSTRACT
| FULL TEXT
Role of Inflammation in Atherosclerosis
Spagnoli et al.
JNM 2007;48:1800-1815.
ABSTRACT
| FULL TEXT
Biochemistry of protein tyrosine nitration in cardiovascular pathology
Peluffo and Radi
Cardiovasc Res 2007;75:291-302.
ABSTRACT
| FULL TEXT
Serum Myeloperoxidase Levels Are Associated With the Future Risk of Coronary Artery Disease in Apparently Healthy Individuals: The EPIC-Norfolk Prospective Population Study
Meuwese et al.
J Am Coll Cardiol 2007;50:159-165.
ABSTRACT
| FULL TEXT
Myeloperoxidase aids prognostication together with N-terminal pro-B-type natriuretic peptide in high-risk patients with acute ST elevation myocardial infarction
Khan et al.
Heart 2007;93:826-831.
ABSTRACT
| FULL TEXT
Myeloperoxidase Interacts with Endothelial Cell-Surface Cytokeratin 1 and Modulates Bradykinin Production by the Plasma Kallikrein-Kinin System
Astern et al.
Am. J. Pathol. 2007;171:349-360.
ABSTRACT
| FULL TEXT
Appraisal of Myeloperoxidase for Evaluation of Patients With Suspected Acute Coronary Syndromes
Morrow
J Am Coll Cardiol 2007;49:2001-2002.
FULL TEXT
Multiple Biomarker Use for Detection of Adverse Events in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome
Apple et al.
Clin. Chem. 2007;53:874-881.
ABSTRACT
| FULL TEXT
Effects of {alpha}-Tocopherol and Mixed Tocopherol Supplementation on Markers of Oxidative Stress and Inflammation in Type 2 Diabetes
Wu et al.
Clin. Chem. 2007;53:511-519.
ABSTRACT
| FULL TEXT
Redefining Risk in Acute Coronary Syndromes Using Molecular Medicine
Anwaruddin et al.
J Am Coll Cardiol 2007;49:279-289.
ABSTRACT
| FULL TEXT
Thiocyanate-Dependent Induction of Endothelial Cell Adhesion Molecule Expression by Phagocyte Peroxidases: A Novel HOSCN-Specific Oxidant Mechanism to Amplify Inflammation
Wang et al.
J. Immunol. 2006;177:8714-8722.
ABSTRACT
| FULL TEXT
Novel model of inflammatory neointima formation reveals a potential role of myeloperoxidase in neointimal hyperplasia
Yang et al.
Am. J. Physiol. Heart Circ. Physiol. 2006;291:H3087-H3093.
ABSTRACT
| FULL TEXT
The T-786C Endothelial Nitric Oxide Synthase Genotype Predicts Cardiovascular Mortality in High-Risk Patients
Rossi et al.
J Am Coll Cardiol 2006;48:1166-1174.
ABSTRACT
| FULL TEXT
The pleiotropic effect of statins in haemodialysis patients is not the consequence of an inhibition of LDL oxidation by myeloperoxidase
Van Antwerpen et al.
Nephrol Dial Transplant 2006;21:2672-2674.
FULL TEXT
L-Arginine Chlorination Results in the Formation of a Nonselective Nitric-Oxide Synthase Inhibitor
Yang et al.
J. Pharmacol. Exp. Ther. 2006;318:1044-1049.
ABSTRACT
| FULL TEXT
Transgenic mice express human MPO -463G/A alleles at atherosclerotic lesions, developing hyperlipidemia and obesity in -463G males
Castellani et al.
J. Lipid Res. 2006;47:1366-1377.
ABSTRACT
| FULL TEXT
Myeloperoxidase Predicts Progression of Carotid Stenosis in States of Low High-Density Lipoprotein Cholesterol
Exner et al.
J Am Coll Cardiol 2006;47:2212-2218.
ABSTRACT
| FULL TEXT
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan
Circulation 2006;113:2335-2362.
FULL TEXT
C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients.
Tsimikas et al.
J Am Coll Cardiol 2006;47:C19-C31.
ABSTRACT
| FULL TEXT
Heparins Increase Endothelial Nitric Oxide Bioavailability by Liberating Vessel-Immobilized Myeloperoxidase
Baldus et al.
Circulation 2006;113:1871-1878.
ABSTRACT
| FULL TEXT
Endothelial function and inflammation in coronary artery disease
Tousoulis et al.
Heart 2006;92:441-444.
ABSTRACT
| FULL TEXT
Statin Treatment and Diabetes Affect Myeloperoxidase Activity in Maintenance Hemodialysis Patients
Stenvinkel et al.
CJASN 2006;1:281-287.
ABSTRACT
| FULL TEXT
Myeloperoxidase Generates 5-Chlorouracil in Human Atherosclerotic Tissue: A POTENTIAL PATHWAY FOR SOMATIC MUTAGENESIS BY MACROPHAGES
Takeshita et al.
J. Biol. Chem. 2006;281:3096-3104.
ABSTRACT
| FULL TEXT
Women and Ischemic Heart Disease: Pathophysiologic Implications From the Women's Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps
Quyyumi
J Am Coll Cardiol 2006;47:S66-S71.
ABSTRACT
| FULL TEXT
The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states
Wang et al.
Blood 2006;107:558-565.
ABSTRACT
| FULL TEXT
Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis
Gritters et al.
Nephrol Dial Transplant 2006;21:153-159.
ABSTRACT
| FULL TEXT
Tyrosine Modification Is Not Required for Myeloperoxidase-induced Loss of Apolipoprotein A-I Functional Activities
Peng et al.
J. Biol. Chem. 2005;280:33775-33784.
ABSTRACT
| FULL TEXT
Myeloperoxidase and Cardiovascular Disease
Nicholls and Hazen
Arterioscler. Thromb. Vasc. Bio. 2005;25:1102-1111.
ABSTRACT
| FULL TEXT
Expression of Human Myeloperoxidase by Macrophages Promotes Atherosclerosis in Mice
McMillen et al.
Circulation 2005;111:2798-2804.
ABSTRACT
| FULL TEXT
Effects of a 5-Lipoxygenase-Activating Protein Inhibitor on Biomarkers Associated With Risk of Myocardial Infarction: A Randomized Trial
Hakonarson et al.
JAMA 2005;293:2245-2256.
ABSTRACT
| FULL TEXT
Myeloperoxidase: friend and foe
Klebanoff
J. Leukoc. Biol. 2005;77:598-625.
ABSTRACT
| FULL TEXT
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Apple et al.
Clin. Chem. 2005;51:810-824.
ABSTRACT
| FULL TEXT
Probucol Protects against Hypochlorite-induced Endothelial Dysfunction: IDENTIFICATION OF A NOVEL PATHWAY OF PROBUCOL OXIDATION TO A BIOLOGICALLY ACTIVE INTERMEDIATE
Witting et al.
J. Biol. Chem. 2005;280:15612-15618.
ABSTRACT
| FULL TEXT
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene?
Coller
Arterioscler. Thromb. Vasc. Bio. 2005;25:658-670.
ABSTRACT
| FULL TEXT
Biochemical risk markers: a novel area for better prediction of renal risk?
Stuveling et al.
Nephrol Dial Transplant 2005;20:497-508.
FULL TEXT
Another look at the age-old question: Which came first, the elevated c-reactive protein or the atherothrombosis?
Sabatine and Braunwald
J Am Coll Cardiol 2005;45:244-245.
FULL TEXT
Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins
Lau et al.
Proc. Natl. Acad. Sci. USA 2005;102:431-436.
ABSTRACT
| FULL TEXT
Localization of Nitration and Chlorination Sites on Apolipoprotein A-I Catalyzed by Myeloperoxidase in Human Atheroma and Associated Oxidative Impairment in ABCA1-dependent Cholesterol Efflux from Macrophages
Zheng et al.
J. Biol. Chem. 2005;280:38-47.
ABSTRACT
| FULL TEXT
Perfusion-assisted beating heart support with a miniature extracorporeal circuit and leukocyte filtration: a 58-year-old patient with severe COPD
Sutton et al.
Perfusion 2004;19:369-373.
ABSTRACT
2-Chlorohexadecanal Derived From Hypochlorite-Modified High-Density Lipoprotein-Associated Plasmalogen Is a Natural Inhibitor of Endothelial Nitric Oxide Biosynthesis
Marsche et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:2302-2306.
ABSTRACT
| FULL TEXT
Leukocyte-Derived Myeloperoxidase Amplifies High-Glucose--Induced Endothelial Dysfunction Through Interaction With High-Glucose--Stimulated, Vascular Non--Leukocyte-Derived Reactive Oxygen Species
Zhang et al.
Diabetes 2004;53:2950-2959.
ABSTRACT
| FULL TEXT
Role of Oxidative Modifications in Atherosclerosis
Stocker and Keaney
Physiol. Rev. 2004;84:1381-1478.
ABSTRACT
| FULL TEXT
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita et al.
Circulation 2004;110:1134-1139.
ABSTRACT
| FULL TEXT
Inhibition of vascular oxidative stress in hypercholesterolemia by eccentric isosorbide mononitrate
Muller et al.
J Am Coll Cardiol 2004;44:624-631.
ABSTRACT
| FULL TEXT
LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22)
Coleman et al.
Blood 2004;104:380-389.
ABSTRACT
| FULL TEXT
Myeloperoxidase and Plaque Vulnerability
Hazen
Arterioscler. Thromb. Vasc. Bio. 2004;24:1143-1146.
FULL TEXT
Hypochlorous Acid, a Macrophage Product, Induces Endothelial Apoptosis and Tissue Factor Expression: Involvement of Myeloperoxidase-Mediated Oxidant in Plaque Erosion and Thrombogenesis
Sugiyama et al.
Arterioscler. Thromb. Vasc. Bio. 2004;24:1309-1314.
ABSTRACT
| FULL TEXT
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker et al.
Circulation 2004;109:IV-6-IV-19.
FULL TEXT
Albumin mediates the transcytosis of myeloperoxidase by means of caveolae in endothelial cells
Tiruppathi et al.
Proc. Natl. Acad. Sci. USA 2004;101:7699-7704.
ABSTRACT
| FULL TEXT
Potential Role of Methionine Sulfoxide in the Inactivation of the Chaperone GroEL by Hypochlorous Acid (HOCl) and Peroxynitrite (ONOO-)
Khor et al.
J. Biol. Chem. 2004;279:19486-19493.
ABSTRACT
| FULL TEXT
Limitations of the Odds Ratio in Gauging the Performance of a Diagnostic, Prognostic, or Screening Marker
Pepe et al.
Am J Epidemiol 2004;159:882-890.
ABSTRACT
| FULL TEXT
Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy
Stenvinkel et al.
Nephrol Dial Transplant 2004;19:972-976.
ABSTRACT
| FULL TEXT
The Role of Oxidative Stress-Altered Lipoprotein Structure and Function and Microinflammation on Cardiovascular Risk in Patients with Minor Renal Dysfunction
Kaysen and Eiserich
J. Am. Soc. Nephrol. 2004;15:538-548.
ABSTRACT
| FULL TEXT
Peroxisome Proliferator-activated Receptor {gamma} Ligands Regulate Myeloperoxidase Expression in Macrophages by an Estrogen-dependent Mechanism Involving the -463GA Promoter Polymorphism
Kumar et al.
J. Biol. Chem. 2004;279:8300-8315.
ABSTRACT
| FULL TEXT
Identification of {alpha}-Chloro Fatty Aldehydes and Unsaturated Lysophosphatidylcholine Molecular Species in Human Atherosclerotic Lesions
Thukkani et al.
Circulation 2003;108:3128-3133.
ABSTRACT
| FULL TEXT
Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases
Zhang et al.
Am. J. Physiol. Heart Circ. Physiol. 2003;285:H2563-H2572.
ABSTRACT
| FULL TEXT
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama and Griendling
Hypertension 2003;42:1075-1081.
ABSTRACT
| FULL TEXT
Class B Scavenger Receptors CD36 and SR-BI Are Receptors for Hypochlorite-modified Low Density Lipoprotein
Marsche et al.
J. Biol. Chem. 2003;278:47562-47570.
ABSTRACT
| FULL TEXT
Is It Safe to Send This Patient Home? ED Markers of ACS Move Upstream
JWatch Emergency Med. 2003;2003:2-2.
FULL TEXT
Novel Risk Markers and Clinical Practice
Manolio
NEJM 2003;349:1587-1589.
FULL TEXT
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan et al.
NEJM 2003;349:1595-1604.
ABSTRACT
| FULL TEXT
Coronary Plaque Morphology and Frequency of Ulceration Distant From Culprit Lesions in Patients With Unstable and Stable Presentation
Schoenhagen et al.
Arterioscler. Thromb. Vasc. Bio. 2003;23:1895-1900.
ABSTRACT
| FULL TEXT
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
Baldus et al.
Circulation 2003;108:1440-1445.
ABSTRACT
| FULL TEXT
Myeloperoxidase-derived Reactive Chlorinating Species from Human Monocytes Target Plasmalogens in Low Density Lipoprotein
Thukkani et al.
J. Biol. Chem. 2003;278:36365-36372.
ABSTRACT
| FULL TEXT
Azithromycin for the Secondary Prevention of Coronary Heart Disease Events: The WIZARD Study: A Randomized Controlled Trial
O'Connor et al.
JAMA 2003;290:1459-1466.
ABSTRACT
| FULL TEXT
Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Myeloperoxidase Promoter Polymorphism
Makela et al.
J. Clin. Endocrinol. Metab. 2003;88:3823-3828.
ABSTRACT
| FULL TEXT
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
Shishehbor et al.
Circulation 2003;108:426-431.
ABSTRACT
| FULL TEXT
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
Locatelli et al.
Nephrol Dial Transplant 2003;18:1272-1280.
ABSTRACT
| FULL TEXT
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernandez-Real and Ricart
Endocr. Rev. 2003;24:278-301.
ABSTRACT
| FULL TEXT
Coronary Artery Calcium and Cardiac Events: Is Electron-Beam Tomography Ready for Prime Time?
Weintraub
Circulation 2003;107:2528-2530.
FULL TEXT
Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy
Shishehbor et al.
JAMA 2003;289:1675-1680.
ABSTRACT
| FULL TEXT
Myeloperoxidase and Plasminogen Activator Inhibitor 1 Play a Central Role in Ventricular Remodeling after Myocardial Infarction
Askari et al.
J. Exp. Med. 2003;197:615-624.
ABSTRACT
| FULL TEXT
C-reactive protein and other inflammatory risk markers in acute coronary syndromes
Blake and Ridker
J Am Coll Cardiol 2003;41:37S-42S.
ABSTRACT
| FULL TEXT
C-Reactive Protein and Ischemia in Users and Nonusers of {beta}-Blockers and Statins: Data From the Heart and Soul Study
Beattie et al.
Circulation 2003;107:245-250.
ABSTRACT
| FULL TEXT
Is Metabolic Syndrome X an Inflammatory Condition?
Das
Exp. Biol. Med. 2002;227:989-997.
ABSTRACT
| FULL TEXT
Characterization of Nitric Oxide Consumption Pathways by Normal, Chronic Granulomatous Disease and Myeloperoxidase-Deficient Human Neutrophils
Clark et al.
J. Immunol. 2002;169:5889-5896.
ABSTRACT
| FULL TEXT
Identification of a Novel Family of Oxidized Phospholipids That Serve as Ligands for the Macrophage Scavenger Receptor CD36
Podrez et al.
J. Biol. Chem. 2002;277:38503-38516.
ABSTRACT
| FULL TEXT
A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions
Podrez et al.
J. Biol. Chem. 2002;277:38517-38523.
ABSTRACT
| FULL TEXT
Novel Markers in the Acute Coronary Syndrome: BNP, IL-6, PAPP-A
Futterman and Lemberg
Am J Crit Care 2002;11:168-172.
FULL TEXT
Defects in leukocyte-mediated initiation of lipid peroxidation in plasma as studied in myeloperoxidase-deficient subjects: systematic identification of multiple endogenous diffusible substrates for myeloperoxidase in plasma
Zhang et al.
Blood 2002;99:1802-1810.
ABSTRACT
| FULL TEXT
Inflammatory Markers in Coronary Artery Disease: Let Prevention Douse the Flames
Vorchheimer and Fuster
JAMA 2001;286:2154-2156.
FULL TEXT
